Readers might be scratching their heads, wondering why Teva still hasn't announced a formal offer for rival pharmaceutical company Mylan despite reports from Bloomberg and the Financial Times this week revealing the Israeli company is was preparing to submit a formal offer of between $86 and $88 a share.
Here are links to the Bloomberg and Financial Times articles:
Showing posts with label Teva. Show all posts
Showing posts with label Teva. Show all posts
Subscribe to:
Posts (Atom)